aspen aerogels inc - ASPN
ASPN
Close Chg Chg %
11.98 0.07 0.54%
Closed Market
12.05
+0.07 (0.54%)
Volume: 3.88M
Last Updated:
Dec 20, 2024, 3:59 PM EDT
Company Overview: aspen aerogels inc - ASPN
ASPN Key Data
| Open $11.70 | Day Range 11.64 - 12.61 |
| 52 Week Range 10.75 - 33.15 | Market Cap $983.75M |
| Shares Outstanding 82.05M | Public Float 80.71M |
| Beta 2.11 | Rev. Per Employee N/A |
| P/E Ratio 1,070.54 | EPS $0.02 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.74M |
ASPN Performance
| 1 Week | -8.30% | ||
| 1 Month | -15.79% | ||
| 3 Months | -56.12% | ||
| 1 Year | -21.65% | ||
| 5 Years | 45.01% |
ASPN Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
About aspen aerogels inc - ASPN
Aspen Aerogels, Inc. engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee in May 2001 and is headquartered in Northborough, MA.
ASPN At a Glance
Aspen Aerogels, Inc.
30 Forbes Road
Northborough, Massachusetts 01532
| Phone | 1-508-691-1111 | Revenue | 238.72M | |
| Industry | Industrial Specialties | Net Income | -45,811,000.00 | |
| Sector | Process Industries | 2023 Sales Growth | 32.353% | |
| Fiscal Year-end | 12 / 2024 | Employees | 548 | |
| View SEC Filings |
ASPN Valuation
| P/E Current | 1,070.54 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 4.59 |
| Price to Book Ratio | 2.474 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -35.278 |
| Enterprise Value to Sales | 4.585 |
| Total Debt to Enterprise Value | 0.127 |
ASPN Efficiency
| Revenue/Employee | 435,616.788 |
| Income Per Employee | -83,596.715 |
| Receivables Turnover | 3.411 |
| Total Asset Turnover | 0.355 |
ASPN Liquidity
| Current Ratio | 3.41 |
| Quick Ratio | 2.909 |
| Cash Ratio | 1.792 |
ASPN Profitability
| Gross Margin | 23.844 |
| Operating Margin | -20.611 |
| Pretax Margin | -19.19 |
| Net Margin | -19.19 |
| Return on Assets | -6.805 |
| Return on Equity | -9.794 |
| Return on Total Capital | -7.308 |
| Return on Invested Capital | -7.703 |
ASPN Capital Structure
| Total Debt to Total Equity | 28.434 |
| Total Debt to Total Capital | 22.139 |
| Total Debt to Total Assets | 19.739 |
| Long-Term Debt to Equity | 28.05 |
| Long-Term Debt to Total Capital | 21.84 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Aspen Aerogels Inc - ASPN
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 100.27M | 121.62M | 180.36M | 238.72M | |
Sales Growth
| -28.06% | +21.29% | +48.30% | +32.35% | |
Cost of Goods Sold (COGS) incl D&A
| 85.68M | 111.69M | 175.39M | 181.80M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 11.17M | 11.06M | 11.86M | 18.18M | |
Depreciation
| 11.17M | 11.06M | 11.86M | 18.18M | |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| -24.24% | +30.35% | +57.04% | +3.65% | |
Gross Income
| 14.59M | 9.94M | 4.98M | 56.92M | |
Gross Income Growth
| -44.48% | -31.91% | -49.92% | +1,043.91% | |
Gross Profit Margin
| +14.55% | +8.17% | +2.76% | +23.84% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 36.16M | 50.54M | 84.22M | 106.12M | |
Research & Development
| 8.73M | 11.44M | 16.93M | 16.36M | |
Other SG&A
| 27.43M | 39.09M | 67.29M | 89.77M | |
SGA Growth
| -10.58% | +39.75% | +66.66% | +26.01% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | (3.73M) | - |
EBIT after Unusual Expense
| (21.57M) | (36.86M) | (79.25M) | (49.20M) | |
Non Operating Income/Expense
| - | - | 1.62M | 8.72M | - |
Non-Operating Interest Income
| - | - | 1.62M | 6.53M | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 240.00K | 229.00K | 5.11M | 5.33M | |
Interest Expense Growth
| -40.89% | -4.58% | +2,131.44% | +4.27% | |
Gross Interest Expense
| 240.00K | 229.00K | 5.11M | 5.33M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (21.81M) | (37.09M) | (82.74M) | (45.81M) | |
Pretax Income Growth
| -49.74% | -70.09% | -123.05% | +44.63% | |
Pretax Margin
| -21.75% | -30.50% | -45.87% | -19.19% | |
Income Tax
| - | - | - | - | - |
Income Tax - Current - Domestic
| - | - | - | - | - |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| - | - | - | - | - |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (21.81M) | (37.09M) | (82.74M) | (45.81M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (21.81M) | (37.09M) | (82.74M) | (45.81M) | |
Net Income Growth
| -49.74% | -70.09% | -123.05% | +44.63% | |
Net Margin Growth
| -21.75% | -30.50% | -45.87% | -19.19% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (21.81M) | (37.09M) | (82.74M) | (45.81M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (21.81M) | (37.09M) | (82.74M) | (45.81M) | |
EPS (Basic)
| -0.8268 | -1.2189 | -2.1019 | -0.6597 | |
EPS (Basic) Growth
| -36.80% | -47.42% | -72.44% | +68.61% | |
Basic Shares Outstanding
| 26.38M | 30.43M | 39.36M | 69.44M | |
EPS (Diluted)
| -0.8268 | -1.2189 | -2.1019 | -0.6597 | |
EPS (Diluted) Growth
| -36.80% | -47.42% | -72.44% | +68.61% | |
Diluted Shares Outstanding
| 26.38M | 30.43M | 39.36M | 69.44M | |
EBITDA
| (10.40M) | (29.54M) | (67.38M) | (31.03M) | |
EBITDA Growth
| -246.78% | -184.05% | -128.10% | +53.96% | |
EBITDA Margin
| -10.37% | -24.29% | -37.36% | -13.00% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 30.727 | |
| Number of Ratings | 11 | Current Quarters Estimate | 0.081 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 0.127 | |
| Last Quarter’s Earnings | -0.17 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.66 | Next Fiscal Year Estimate | 0.468 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 7 | 10 | 10 |
| Mean Estimate | 0.08 | 0.05 | 0.13 | 0.47 |
| High Estimates | 0.10 | 0.11 | 0.29 | 0.62 |
| Low Estimate | 0.04 | 0.00 | 0.06 | 0.27 |
| Coefficient of Variance | 26.47 | 65.87 | 47.69 | 23.01 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 10 | 10 | 10 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Aspen Aerogels Inc - ASPN
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Aspen Aerogels Inc - ASPN
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 20, 2024 | Koch Industries, Inc. | N/A | Open market or private sale of non-derivative or derivative security | 0.00 |
| Jun 4, 2024 | Virginia H. Johnson CLO, GC, Secretary & CCO | 27,132 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $29.92 per share | 811,789.44 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 625,117 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.78 per share | 6,738,761.26 |
| May 30, 2024 | Donald R. Young President and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 296,771 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 30, 2024 | Donald R. Young President and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 30, 2024 | Donald R. Young President and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 622,880 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $29.38 per share | 18,300,214.40 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 799,626 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $6.4 per share | 5,117,606.40 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 502,855 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $29.72 per share | 14,944,850.60 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 529,141 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $29.18 per share | 15,440,334.38 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 759,799 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $6.4 per share | 4,862,713.60 |
| May 30, 2024 | Donald R. Young President and CEO; Director | 733,222 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $7.54 per share | 5,528,493.88 |
| May 24, 2024 | Kathleen M. Kool Director | 16,155 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $12.15 per share | 196,283.25 |
| May 24, 2024 | Kathleen M. Kool Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 24, 2024 | Kathleen M. Kool Director | 11,685 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.3 per share | 319,000.50 |
| May 15, 2024 | Keith L. Schilling SVP, Technology | 48,792 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $6.81 per share | 332,273.52 |
| May 15, 2024 | Keith L. Schilling SVP, Technology | 29,292 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $26.83 per share | 785,904.36 |
| May 15, 2024 | Keith L. Schilling SVP, Technology | 28,792 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27.42 per share | 789,476.64 |
| May 15, 2024 | Keith L. Schilling SVP, Technology | 55,979 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |